Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA

NCT03119701 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
40
Enrollment
INDUSTRY
Sponsor class

Stopped IDMC recommendation. Unexpectedly high use of concomitant corticosteroid treatment.

Conditions

Interventions

Sponsor

Faron Pharmaceuticals Ltd